Opinions regarding the Academy of Managed Care Pharmacy dossier submission guidelines: Results of a small survey of managed care organizations and pharmaceutical manufacturers

Journal of Managed Care Pharmacy

Volumn 13, Issue 4, 2007, Pages 360-371

  Nichol, Michael B ^a   Knight, Tara K ^a   Epstein, Joshua ^a   Honda, Dennis H ^b   Tretiak, Roma ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b US Regional Medical and Research Specialist   (United States)

^c PFIZER INC   (United States)

Author keywords

AMCP Format; Economic models; Formulary decision making

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG FORMULARY; DRUG INDUSTRY; DRUG SCREENING; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; MANAGED CARE; MANAGED CARE ORGANIZATION; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; STRUCTURED INTERVIEW;

EID: 34250757975     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2007.13.4.360     Document Type: Article

References (16)

1. Suh D, Okpara IR, Agnese WB, Toscani M. Application of pharmocoeconomics to formulary decision making in managed care organizations. Am J Manag Care. 2002;8(2):161-69.
2. Mather D, Sullivan SD, Augenstein D, Fullerton DS, Atherly D. Incorporating clinical outcomes and economic consequences into drug formulary decisions: a practical approach. Am J Manag Care. 1999;5(3):277-85.
3. Fullerton D, Atherly D, Sullivan SD. Showing outcomes and proving value brings success. Manag Care Interface. 2001;14(6):63-65.
4. Atherly DE. Incorporating clinical outcomes and economic consequences into drug formulary decisions: evaluation of thirty months of experience. Value Health. 2001;4(2):52.
5. Neumann P. Evidence-based and value-based formulary guidelines. Health Aff. 2004;23(1):124-34.
6. Robinson A. AMCP's Format for Formulary Submissions: an evolving standard - results of two recent surveys. Presentation at: the Fifteenth Annual Meeting of the Academy of Managed Care Pharmacy; April 9-12, 2003; Minneapolis, MN.
7. Fullerton P, Atherly DS. Formulary development at Regence BlueShield - a formula for success. Value Health. 2002;5(4):297-300.
8. Watkins JB, Minshall ME, Sullivan SD. Application of economic analyses in U.S. managed care formulary decisions: a private payer's experience. J Manag Care Pharm. 2006;12(9):726-35. Available at: http://www.amcp.org/data/jmcp/726-735.pdf. Accessed April 17, 2007.
9. Sullivan P, Valuck R, Brixner DI, Armstrong EP. Managed care's response to a pharmacoeconomic model of serotonin reuptake inhibitors. Pharm Ther 2005;30(3):178-82.
10. Olson B, Armstrong EP, Grizzle AJ, Nichter MA. Industry's perception of presenting pharmacoeconomic models to managed care organizations. J Manag Care Pharm. 2003;9(2):159-67. Available at: http://www.amcp.org/data/jmcp/Formulary%20Management-159-167.pdf. Accessed April 17, 2007.
11. DiMasi JA, Caglarcan E, Wood-Armany M. Emerging role of pharmacoeconomics in the research and development decision-making process. Pharmacoeconomics. 2001;19(7):753-66.
12. Armstrong E, Abarca J, Grizzle AJ. The role of pharmacoeconomic information from the pharmaceutical perspective. Drug Benefit Trends. 2001;13(3):39-45.
13. Delate T, Ernst FR, Coons SJ. The role of health-related quality-of-life data in pharmacy benefit decisions. Pharm Ther. 2002;27(1):24,30-32.
14. Spooner J, Gandhi PK, Connelly SB. AMCP Format dossier requests: manufacturer response and formulary implications for one large health plan. J Manag Care Pharm. 2007;13(1):37-43. Available at: http://wwwamcp.org/data/jmcp/37-43.pdf. Accessed April 17, 2007.
15. Academy of Managed Care Pharmacy. A format for submission of clinical and economic data in support of formulary consideration by health care systems in the United States. The AMCP Format for Formulary Submissions, Version 2.1. April 2005. Available at: http://www.fmcpnet.org/index.cfm?pl=ADEE1897. Accessed April 17, 2007.
16. Centers for Medicare & Medicaid Services. Medicare Modernization Act final guidelines - formularies. CMS strategy for affordable access to comprehensive drug coverage. Guidelines for reviewing prescription drug plan formularies and procedures. Available at: http://www.cms.hhs.gov/ PrescriptionDrugCovContra/Downloads/FormularyGuidance.pdf. Accessed November 21, 2006.